New brain scan dye tested as safer alternative
Diagnosis
Completed
This study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC